CVRx (CVRX) Share-based Compensation Growth (1y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 9.69% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 3.57% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -4.08% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 12.16% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 12.94% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 26.61% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 59.09% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 31.63% |
| 10 | CVRx | 144.43 Mn | 72.13 Mn | 12.88 Mn | 18.78% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.78% |
| Dec 31, 2025 | 4.02% |
| Sep 30, 2025 | 7.76% |
| Jun 30, 2025 | 14.62% |
| Mar 31, 2025 | -77.96% |
| Dec 31, 2024 | 68.87% |
| Sep 30, 2024 | 74.93% |
| Jun 30, 2024 | 72.36% |
| Mar 31, 2024 | 553.43% |
| Dec 31, 2023 | 49.30% |
| Sep 30, 2023 | 64.91% |
| Jun 30, 2023 | 34.18% |
| Mar 31, 2023 | 115.01% |
| Dec 31, 2022 | 41.43% |
| Sep 30, 2022 | 95.99% |
| Jun 30, 2022 | 76.28% |
| Mar 31, 2022 | 1,200.00% |
| Dec 31, 2021 | 1,935.14% |
| Sep 30, 2021 | 1,429.03% |
| Jun 30, 2021 | 1,850.00% |